MCCARTHY SEAN A. (President and CEO) sold 9.3% of their position (101.79K shares) of CYTOMX THERAPEUTICS, INC. on the open market
Open‑market sale worth $461.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/10/2025ACC: 0001610717-25-000372
DirectorOfficer· President and CEO
Since Jul 2018
-101.79K
Net shares
Net seller
$461.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
101.79K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−101.79K
Price / share
$4.54
Trade value
$461.91K
% of position
9.3%
11/6/2025
1.09M→987.89K
Total
Net shares
−101.79K
Net value
-$461.91K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 11/6/2025 | S · Sale | −101.79K | $4.54 | $461.91K | 9.3% | 1.09M | 987.89K |
| Total | −101.79K | -$461.91K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Class A Common Stock
IndirectShares owned93.16K
Total
93.16K indirect93.16K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 93.16K | Indirect |
| Total | 93.16K | 93.16K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported